Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-09-30 pm EDT
507.19 USD   -1.82%
09/29Thermo Fisher Scientific Enters Power Purchase Agreement With Enel North America
MT
09/29Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
BU
09/28Thermo Fisher Scientific Launches A More Sustainable Solution for Large-Scale Cell Culture Harvesting
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis

08/03/2022 | 08:01am EDT

New Embedded CryoSPARC Live software to be made available by Structura and Thermo Fisher and designed to integrate with Thermo Fisher technology

Thermo Fisher Scientific Inc., the world leader in serving science, and Structura Biotechnology Inc., a leading provider of cryo-EM data analysis software, today announced a collaboration to make available a new single particle analysis software solution, a version of Structura’s CryoSPARC Live, that is designed to integrate with Thermo Fisher’s Smart EPU software and cryo-transmission electron microscope (cryo-TEM) technology. The new solution, Embedded CryoSPARC Live, will be offered as a subscription.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220803005011/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

Embedded CryoSPARC Live will enable cryo-electron microscopy (cryo-EM) users of all experience levels to obtain high-quality data while reducing the time it takes to transform raw data into high-quality 3D protein structures from days to hours.

Embedded CryoSPARC Live will offer real-time cryo-EM data analysis, including pre-processing (motion correction and CTF estimation), particle picking and extraction, streaming 2D classification, ab-initio 3D reconstruction, and streaming 3D refinement. This workflow will enable users to make decisions to optimize data acquisition and can be used as an input for Smart EPU plugins, which automatically adjust EPU data acquisition parameters in real-time.

“We’re thrilled to make this announcement with Structura Biotechnology as we work together to make cryo-EM more accessible, productive and easy to use,” said Trisha Rice, vice president and general manager of life sciences at Thermo Fisher Scientific. “This solution represents a major step forward in our plans to deliver a fully automated and intelligent cryo-EM imaging platform.”

“We’re excited to collaborate with Thermo Fisher Scientific and deliver a powerful solution that will help users in research and commercial settings move toward a more optimized and high-throughput cryo-EM workflow,” said Ali Punjani, CEO at Structura Biotechnology.

Embedded CryoSPARC Live will soon be available as an add-on for Smart EPU users and can be configured to connect to Thermo Fisher’s entire cryo-TEM portfolio, including the Thermo Scientific Tundra, Glacios and Krios Cryo-TEMs.

To learn more, visit our Embedded CryoSPARC Live webpage.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.


© Business Wire 2022
All news about THERMO FISHER SCIENTIFIC
09/29Thermo Fisher Scientific Enters Power Purchase Agreement With Enel North America
MT
09/29Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power P..
BU
09/28Thermo Fisher Scientific Launches A More Sustainable Solution for Large-Scale Cell Cult..
CI
09/28Thermo Fisher Scientific's Cancer Screening Technology Gets FDA Approval
MT
09/27Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First..
CI
09/22Thermo Fisher Scientific Partners with Pennsylvania Biotechnology Center to Support Lif..
AQ
09/21Thermo Fisher Scientific Opens Biomanufacturing Facility in Massachusetts
MT
09/20Thermo Fisher Scientific : Invests $160 Million to Expand Bioproduction Capacity in Greate..
PU
09/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
09/13Thermo Fisher Scientific Collaborates with Taiwan Precision Medicine Initiative to Geno..
CI
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 43 199 M - -
Net income 2022 6 924 M - -
Net Debt 2022 24 596 M - -
P/E ratio 2022 29,0x
Yield 2022 0,23%
Capitalization 199 B 199 B -
EV / Sales 2022 5,17x
EV / Sales 2023 4,96x
Nbr of Employees 130 000
Free-Float 88,7%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 507,19 $
Average target price 658,24 $
Spread / Average Target 29,8%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors